GS
75
2
LH
43
-2
BWA
48
2
PEP
48
6
PM
62
-2
XRX
44
3
CA
38
6
NDAQ
62
2
NWL
53
3
TROW
56
5
R
71
4
ROST
63
12
COF
60
2
PRGO
39
3
IBM
58
-2
AN
58
4
AAP
24
6
BSX
67
-3
GE
67
2
SNA
68
-2
GS
75
2
LH
43
-2
BWA
48
2
PEP
48
6
PM
62
-2
XRX
44
3
CA
38
6
NDAQ
62
2
NWL
53
3
TROW
56
5
R
71
4
ROST
63
12
COF
60
2
PRGO
39
3
IBM
58
-2
AN
58
4
AAP
24
6
BSX
67
-3
GE
67
2
SNA
68
-2
Financhill
Back

Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
34

NONOF
Novo Nordisk AS

Last Price:
105.00
Seasonality Move:
10.92%
Sell
27

ASND
Ascendis Pharma AS

Last Price:
130.01
Seasonality Move:
20.86%
Sell
34
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $105.00. The Score for NONOF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $129.81. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $129.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.62 Sell
Relative Strength Index (14 RSI): 43.48 Sell
Chaikin Money Flow: 2764 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.94 - 113.82) Sell
Bollinger Bands (100): (112.96 - 136.26) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 53.83 Buy
Chaikin Money Flow: 334016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.01 - 129.03) Buy
Bollinger Bands (100): (124.29 - 141.45) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.57 Buy
20-day SMA: 107.02 Sell
50-day SMA: 115.37 Sell
200-day SMA: 127.7 Sell
8-day EMA: 104.31 Buy
20-day EMA: 107.24 Sell
50-day EMA: 114.19 Sell
200-day EMA: 120.35 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.01 Buy
20-day SMA: 125.87 Buy
50-day SMA: 133.06 Sell
200-day SMA: 136.78 Sell
8-day EMA: 125.66 Buy
20-day EMA: 126.61 Buy
50-day EMA: 129.57 Buy
200-day EMA: 130.24 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):